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Edited by Shou-Wei DingAbstract Short interfering RNAs (siRNAs) variously modiﬁed
with 4 0-thioribonucleosides against the Photinus luciferase gene
were tested for their induction of the RNA interference (RNAi)
activity in cultured NIH/3T3 cells. Results indicated that modi-
ﬁcations at the sense-strand were well tolerated for RNAi activ-
ity except for full modiﬁcation with 4 0-thioribonucleosides.
However, the activity of siRNAs modiﬁed at the antisense-strand
was dependent on the position and the number of modiﬁcations
with 4 0-thioribonucleosides. Since modiﬁcations of siRNAs with
4 0-thioribonucleosides were well tolerated in RNAi activity com-
pared with that of 2 0-O-methyl nucleosides, 4 0-thioribonucleo-
sides might be potentially useful in the development of novel
and eﬀective chemically modiﬁed siRNAs.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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RNA interference (RNAi) is a highly conserved biological
response to double-stranded RNA that mediates post-tran-
scriptional gene silencing [1]. After the discovery of RNAi by
short interfering RNAs (siRNAs) [2], which are approximately
21 nucleotides in length with 3 0 nucleotides overhang, much ef-
fort has been dedicated to the application of siRNAs not only
as biological tools but also as therapeutic agents. However,
since RNA is a transient molecule in biological ﬂuids, the
development of a chemically modiﬁed siRNA that conferred
nuclease resistance would be a tremendously valuable tool.
Thus far, several groups have reported RNAi activity of siR-
NAs with various chemical modiﬁcations [3–9]. These ap-
proaches are mainly divided into two classes, i.e.,
modiﬁcations of the phosphodiester-backbone [4–6,8] and
the ribose moiety [5–9]. In the ﬁrst case, modiﬁcation with
phosphorothioates [5,6,8] and boranophosphates [4] has been
examined. Hall et al. [4] found that boranophosphate siRNAs
are consistently more eﬀective than phosphorothioate siRNAs.
Furthermore, boranophosphate siRNAs are frequently moreAbbreviations: siRNA, short interfering RNA; RNAi, RNA interfer-
ence; RISC, RNA-induced silencing complex
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doi:10.1016/j.febslet.2005.04.073active than natural siRNA if the center of the antisense-strand
is not modiﬁed. As for the ribose moiety, siRNAs modiﬁed
with 2 0-deoxy [6], 2 0-O-methyl [5,6,8,9] and 2 0-ﬂuoro [5–7]
groups also have been investigated for RNAi activity. Several
groups [6,7] have reported that 2 0-ﬂuoro modiﬁcations are well
tolerated for RNAi activity and enhance serum stability.
Amarzguioui et al. [8] reported that certain siRNA species with
2 0-O-methyl modiﬁcations showed long-term RNAi activity.
In addition, Czauderna et al. [9] found that the 2 0-O-methyl
modiﬁcations at speciﬁc positions improve the stability of siR-
NA in serum and are tolerated without any signiﬁcant loss of
RNAi activity. However, thus far no overwhelming informa-
tion for the best choice of modiﬁcation of siRNA has come
forth.
On the other hand, the synthesis and properties of oligonu-
cleotides containing 4 0-thioribonucleosides (4 0-thioRNAs)
(Fig. 1) have been reported by our lab [10] and others
[11,12]. The 4 0-thioRNA formed a thermally stable duplex
with the complementary RNA and 4 0-thioRNA, and showed
high nuclease resistance, despite of possessing the 2 0-OH
groups. In addition, structural analysis by CD spectra
indicated that the 4 0-thioRNA:4 0-thioRNA duplex and 4 0-
thioRNA:RNA duplex adopt an A-form conformation as does
the natural RNA duplex. These results prompted us to inves-
tigate whether modiﬁcations of siRNA with 4 0-thioribonucleo-
sides inﬂuenced RNAi inducing activity. We report herein the
ﬁrst study of the structure–activity relationship of siRNAs
modiﬁed with 4 0-thioribonucleosides for RNAi activity.2. Materials and methods
2.1. Preparation of siRNA modiﬁed with 4 0-thioribonucleosides
Oligonucleotides containing 4 0-thioribonucleosides [13] were synthe-
sized on a DNA synthesizer (Applied Biosystems Model 392), as we
previously reported [10]. For preparation of duplexes, sense- and anti-
sense-strand oligonucleotides (20 lM each) were mixed together in an
annealing buﬀer (100 mM potassium acetate, 30 mM HEPES-KOH at
pH 7.4, 2 mM magnesium acetate) and incubated for 1 min at 90 C
then overnight at room temperature. All siRNA duplexes were synthe-
sized with 2 nt deoxythymidine 3 0-overhangs and directed against
photinus luciferase, as described by Elbashir et al. [2]. Scramble siRNA
duplex (B-bridge) was used as a negative control.2.2. Cell culture, transfection, and dual luciferase assay
NIH/3T3 cells were grown at 37 C in Dulbeccos modiﬁed Eagles
medium (Gibco/BRL) supplemented with 10% fetal bovine serum
(FBS), 100 units mL1 penicillin, and 100 lg mL1 streptomycin. Cells
were regularly passaged to maintain exponential growth. Twenty-four
hours before transfection at 70–90% conﬂuency, cells were diluted withblished by Elsevier B.V. All rights reserved.
Table 1
Sequence, RNAi activity and IC50 of siRNA modiﬁed with 4
0-
thioribonucleosides or 2 0-O-methyl nucleosides
Name Sequence RNAi activity
(%)
IC50 (nM)
scramble 0±13.3 n.d.
RNA1 95.4±0.4 0.10±0.03
RNA2 96.3±0.2 n.d.
RNA3 93.6±0.4 n.d.
RNA4 92.9±0.7 0.12±0.06
RNA5 60.3±1.4 n.d.
RNA6 79.5±1.3 1.65±1.08
RNA7 68.5±4.2 2.09±1.43
RNA8 27.5±4.3 n.d.
n.d.
n.d.
n.d.
RNA9 16.6±2.3
RNA10 94.0±0.4
RNA11 93.8±0.3
S
OHHO
HO B
B = U, C, A, G
Fig. 1. Structure of 4 0-thioribonucleosides.
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(500 lL per well). Co-transfection of reporter plasmids and siRNAs
was carried out with Lipofectamine 2000 (Life Technologies), as de-
scribed by the manufacturer. Before co-transfection, the culture med-
ium was replaced with 0.5 mL of fresh medium without antibiotics,
and to each well 1.0 lg pGL2-Control (Promega), 0.1 lg pRL-TK
(Promega), and siRNA duplex formulated into liposomes were ap-
plied; the ﬁnal volume was 600 lL per well. After a 6 h incubation at
37 C, the culture medium was replaced with 0.5 mL of fresh medium
supplemented with 10% FBS and antibiotics, and further incubated at
37 C. Twenty-four hours after transfection, the cell lysate was pre-
pared and luciferase expression was subsequently monitored with the
Dual-Luciferase reporter assay system (Promega). The IC50 value of
each siRNA was estimated from a seven-point dose–response analysis.RNA12 87.4±0.4 0.31±0.09
RNA13 91.5±1.2 0.16±0.05
RNA14 70.9±2.4 2.62±0.70
RNA15 72.2±1.5 1.98±1.15
RNA16 36.5±7.8 n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
RNA17 22.8±8.5
RNA18 94.8±0.6
RNA19 94.2±1.4
RNA20 10.3±16.2
RNA21 30.8±10.5
Modiﬁcations with 4 0-thioribonucleosides are indicated in red.
Modiﬁcations with 20-O-methyl nucleosides are indicated in green.
RNAi activity was quantiﬁed by the dual luciferase assay and is
presented as the inhibition eﬃciency of target gene (photinus luciferase)
when cells were treated with 25 nM modiﬁed siRNAs.
n.d. means not determined.3. Results
3.1. RNAi inducing activity of siRNA modiﬁed with
4 0-thioribonucleosides
We prepared modiﬁed siRNA directed against photinus
luciferase as described by Elbashir et al. [2]. We carried out
the siRNA-luciferase reporter assay and investigated whether
modiﬁcations of siRNA with 4 0-thioribonucleosides inﬂuenced
RNAi inducing activity in NIH/3T3 cells. The sequences,
RNAi activity at 25 nM, and IC50 values of modiﬁed siRNA
are shown in Table 1. The siRNAs (RNA2–RNA4) partially
modiﬁed with 4 0-thioribonucleosides at the sense-strand (upper
strand) almost equaled natural siRNA (RNA1) in RNAi activ-
ity. RNAi activity was still observed even when all the residues
of the sense-strand were modiﬁed (RNA5). On the other hand,
the activity was drastically aﬀected by the modiﬁcation at the
antisense-strand (lower strand). The RNAi activity was re-
duced to some degree when uridine or cytidine residues were
substituted for 4 0-thiouridine or 4 0-thiocytidine (RNA6 and
RNA7). From the comparison of IC50 values, their activities
were 15–20 fold less than that of RNA1, however they were
still eﬀective for gene suppression. Further modiﬁcations with
4 0-thioribonucleosides resulted in a signiﬁcant loss of RNAi
activity (RNA8 and RNA9).
We next tested RNAi using siRNAs consecutively modiﬁed
with 4 0-thioribonucleosides on their 5 0-end, 3 0-end and both
ends, and central position (RNA10–RNA17). This mode of
modiﬁcation, especially with RNA13 and RNA17, was carried
out according to the strategy for antisense molecules, namely a
gapmer [14,15]. All of the modiﬁed siRNAs on their sense-
strand (RNA10–RNA13) were almost equal to the natural
siRNA (RNA1) in RNAi activity. On the other hand, the
RNAi activity was reduced somewhat compared with that of
RNA1 when the 5 0- or 3 0-end of the antisense strand was mod-
iﬁed (RNA14 and RNA15). The RNAi activity of RNA16,
modiﬁed on the central position of the antisense strand, was
fairly lower than RNA14 and RNA15, although the number
of modiﬁcation was nearly equal. Furthermore, modiﬁcationof the both ends (RNA17) resulted in loss of RNAi activity.
These results were almost compatible with the case of
RNA2–RNA9.
In order to evaluate the utility of the chemical modiﬁcation
of siRNA with 4 0-thioribonucleosides, time-course experi-
ments of RNAi activity were examined. As shown in Fig. 2,
the RNAi activity of the natural siRNA (RNA1) was still
the most eﬀective after 3 days in comparison with those of
RNA4 and RNA13. However, after 5 days, the modiﬁed siR-
NAs showed higher RNAi activity than natural RNA1. We
next compared the RNAi activity of siRNAs modiﬁed with
2 0-O-methyl nucleosides, i.e., RNA18–RNA21 vs. RNA10,
RNA11, RNA14 and RNA15. Modiﬁcation with 2 0-O-methyl
nucleosides is recognized as a promising candidate for chemi-
cally modiﬁed siRNA [8,9]. The siRNAs modiﬁed with 2 0-O-
methyl nucleosides on the sense-strand (RNA18 and
RNA19), like RNA10 and RNA11, showed potent RNAi
Table 2
Sequence, RNAi activity and IC50 of siRNA containing two
mismatches at the 3 0-end of the sense-strand or phosphorylated at
the 5 0-end of the antisense-strand
Name Sequence RNAi activity(%) IC50 (nM)
RNA1 5'-CGUACGCGGAAUACUUCGATT-3'
3'-TTGCAUGCGCCUUAUGAAGCU-5'
95.4±0.4 0.10±0.03
RNA7 5'-CGUACGCGGAAUACUUCGATT-3'
3'-TTGCAUGCGCCUUAUGAAGCU-5'
68.5±4.2 2.09±1.43
RNA23 5'-CGUACGCGGAAUACUUCGATT-3'3'-TTGCAUGCGCCUUAUGAAGCU-p-5' 62.8±3.0 5.30±1.34
RNA24 5'-CGUACGCGGAAUACUUCUCTT-3'
3'-TTGCAUGCGCCUUAUGAAGCU-5'
72.3±1.4 3.32±1.04
RNA14 5'-CGUACGCGGAAUACUUCGATT-3'
3'-TTGCAUGCGCCUUAUGAAGCU-5'
70.9±2.4 2.62±0.70
RNA25 5'-CGUACGCGGAAUACUUCGATT-3'3'-TTGCAUGCGCCUUAUGAAGCU-p-5' 72.9±7.1 3.39±1.67
RNA26 5'-CGUACGCGGAAUACUUCUCTT-3'
3'-TTGCAUGCGCCUUAUGAAGCU-5'
69.0±1.2 4.84±0.61
Modiﬁcations with 40-thioribonucleosides are indicated in red.
Mismatches are indicated in blue.
RNAi activity was quantiﬁed by the dual luciferase assay and is
presented as the inhibition eﬃciency of target gene (photinus luciferase)
when cells were treated with 25 nM modiﬁed siRNAs.
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niﬁcantly when the antisense-strand was modiﬁed (RNA20
and RNA21) relative to RNA1, and was much lower than
the activity of RNA14 and RNA15. These results indicate that
modiﬁcation with 4 0-thioribonucleosides were well tolerated in
RNAi activity compared to that with 2 0-O-methyl nucleosides,
at least, in a certain type of modiﬁcation.
3.2. Eﬀects of additional mechanism-based modiﬁcations of
siRNA molecules
The RNAi machinery is complex. Although still unclear,
RNAi induced by siRNA is thought to require: (1) phosphor-
ylation of the 5 0-end(s) of siRNA by unknown kinase(s), (2)
incorporation of the phosphorylated siRNA into RISC
(RNA-induced silencing complex) via multiple steps starting
with unwinding by helicase, and (3) sequence selective cleavage
of target RNA by endonuclease activity of the RISC (reviewed
in [16]). As shown in the previous section, modiﬁcation of siR-Fig. 2. Persistence of silencing of the expression of Photinus luciferase
gene with siRNA modiﬁed with 4 0-thioribonucleosides at 25 nM. The
data of the RNA1, RNA4, and RNA13 are indicated in gray, red and
blue, respectively. Data are averages of at least three independent
experiments. Error bars indicate standard deviations. Statistical
analyses were carried out by using Students t-test. Asterisk indicates
statistically signiﬁcant diﬀerence (P < 0.05) against the data of the
RNA1.NA with 4 0-thioribonucleosides generally resulted in a decrease
in RNAi activity proportional to the number of modiﬁcations,
especially on the antisense-strand. Thus, we next investigated
why modiﬁcation with 4 0-thioribonucleosides inﬂuenced RNAi
activity through additional mechanism-based modiﬁcations of
siRNA (Table 2).
The ﬁrst possibility suggested that the eﬃciency of the phos-
phorylation of the modiﬁed siRNA might aﬀect its RNAi
activity. Since the gene suppression is abolished when the 5 0-
end of the antisense-strand is blocked, and the 5 0-end of the
sense-strand is not necessary to be phosphorylated [17,18],
we compared the RNAi activity of the siRNAs phosphorylated
at the 5 0-end of the antisense strand (RNA23 and RNA25)
with that of unphosphorylated siRNAs (RNA7 and
RNA14). However, the RNAi activity of RNA23 and
RNA25 was not restored relative to RNA7 and RNA14.
To further test the eﬀect of the chemical modiﬁcation with
4 0-thioribonucleosides, we then concentrated on the thermal
stability of siRNAs. Recently, Schwarz et al. [19] and Khvor-
ova et al. [20] reported that siRNA is an asymmetric molecule
for RISC formation and the strand with relatively lower ther-
mal stability in the 5 0-end is preferentially incorporated into
RISC. This was also conﬁrmed by Hohjoh [21], who reported
that siRNA carrying mismatches at the 3 0-end of the sense
strand could enhance RNAi activity over conventional siRNA.
Since oligonucleotides containing 4 0-thioribonucleosides form
thermally more stable duplexes with the natural RNA than
natural RNA duplex [10], it could be that thermal stabilization
arising from modiﬁcation with 4 0-thioribonucleosides reduces
the eﬃciency of incorporation into RISC. Based on these con-
siderations, we compared the RNAi of matched siRNAs
(RNA7 and RNA14) with that of siRNAs containing mis-
matches on the 3 0-end of the sense strand (RNA24 and
RNA26). However, we found that RNAi activity was not re-
stored relative to the matched siRNAs. The results of these
two types of additional modiﬁcations led us to conclude that
modiﬁcations of siRNAs with 4 0-thioribonucleosides do not
inﬂuence the eﬃciency of phosphorylation at the 5 0-end nor
the thermal stability of siRNAs, which would aﬀect the acces-
sibility of helicase to the asymmetric siRNA.4. Discussion
We have thus shown the ﬁrst example of RNAi induced by
siRNAs modiﬁed with 4 0-thioribonucleosides in NIH/3T3
cells. These results indicated that the RNAi of siRNAs modi-
ﬁed with 4 0-thioribonucleosides is dependent on the number
and the position of the modiﬁcations, especially in the anti-
sense-strand. In addition, the central position of the antisense-
strand was found to be most sensitive to the modiﬁcation as
seen by the comparison of the activities of RNA14–RNA16.
This result would appear to be a reasonable assumption
because RISC cleaves mRNAs at 10 nucleotides from the
5 0-end, i.e., the central position of a 21-nucleotide siRNA
[22]. As is commonly recognized, the RNAi machinery is still
unclear and quite complex compared with the mechanism of
antisense. The gapmer-like mode of modiﬁcation was ineﬀec-
tive as can be seen in the result of RNA17, and the critical ele-
ments for modiﬁed siRNAs would seem to lie in other steps,
including RISC formation, for example. Since phosphoryla-
tion and incorporation of the mismatch of siRNAs did not
3118 S. Hoshika et al. / FEBS Letters 579 (2005) 3115–3118restore their RNAi activity, other factors should be considered
for the modiﬁcation with 4 0-thioribonucleosides–RNAi activ-
ity relationship. One possible explanation is the structural
change of siRNAs modiﬁed with 4 0-thioribonucleosides. In
our previous paper [10], we reported that not only the 4 0-thi-
oRNA:RNA duplex but also the 4 0-thioRNA:4 0-thioRNA
adopts the A-conformation for their mode of base stacking.
However, the conformational change of the phosphate–sugar
backbone, probably aﬀecting the minor groove of the duplex,
arising from the substitution of a furanose ring oxygen by a
sulfur atom, was also suggested. This small but critical struc-
tural change would aﬀect RISC formation of the modiﬁed siR-
NAs. Chiu et al. [6] suggested that the A-conformation of
siRNA is required for RNAi induction, and furthermore, that
the structure of the major groove of the siRNA is an essential
determinant for RISC formation. Our results may also indicate
an importance of the structure of the minor groove for RISC
formation. Further investigation of modiﬁcation–RNAi activ-
ity relationship should reveal the structural requirements of
RNAi induction.
Thus far, several kinds of modiﬁed siRNAs described in Sec-
tion 1 were under investigation toward therapeutic use. How-
ever RNAi activity is altered by not only the mode of
modiﬁcation but also the conditions including the target se-
quence and the cell lines used, and it is still diﬃcult to deter-
mine the best choice of chemical modiﬁcation of siRNA.
Since modiﬁcations of siRNAs with 4 0-thioribonucleosides im-
proved long-term silencing eﬀect compared with natural siR-
NA and were well tolerated in RNAi activity compared with
2 0-O-methyl nucleosides, 4 0-thioribonucleosides might have
potential for the development of novel and eﬀective chemically
modiﬁed siRNAs.
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